1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
(
- Contribution to journal › Article
- 2021
-
Mark
The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
(
- Contribution to journal › Article
- 2020
-
Mark
Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease
(
- Contribution to journal › Article
-
Mark
The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue
(
- Contribution to journal › Article
- 2019
-
Mark
Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids
(
- Contribution to journal › Article
- 2017
-
Mark
Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - An 11-Year Prospective Study
(
- Contribution to journal › Article
-
Mark
Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans
(
- Contribution to journal › Article
- 2015
-
Mark
Liver Fat Content and Hepatic Insulin Sensitivity in Overweight Patients With Type 1 Diabetes
(
- Contribution to journal › Article
- 2013
-
Mark
Adipocyte Size is Associated with NAFLD Independent of Obesity, Fat Distribution, and PNPLA3 Genotype
(
- Contribution to journal › Article
-
Mark
Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects
(
- Contribution to journal › Article